TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $224,000 | +9.8% | 2,075 | 0.0% | 0.01% | +20.0% |
| Q3 2018 | $204,000 | -15.0% | 2,075 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $240,000 | +17.1% | 2,075 | 0.0% | 0.01% | +20.0% |
| Q1 2018 | $205,000 | -5.5% | 2,075 | 0.0% | 0.01% | -9.1% |
| Q4 2017 | $217,000 | -7.3% | 2,075 | 0.0% | 0.01% | -8.3% |
| Q3 2017 | $234,000 | +0.4% | 2,075 | 0.0% | 0.01% | -7.7% |
| Q2 2017 | $233,000 | -3.7% | 2,075 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $242,000 | +11.0% | 2,075 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $218,000 | -4.8% | 2,075 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $229,000 | -24.2% | 2,075 | 0.0% | 0.01% | -27.8% |
| Q2 2016 | $302,000 | +1.7% | 2,075 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $297,000 | -7.5% | 2,075 | 0.0% | 0.02% | -5.3% |
| Q4 2015 | $321,000 | +8.4% | 2,075 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $296,000 | -0.7% | 2,075 | 0.0% | 0.02% | +5.6% |
| Q2 2015 | $298,000 | – | 2,075 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |